Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives

Ph+ chronic myeloid leukemia (CML) is a clonal myeloproliferative disease whose clinical course is characterized by progression disease from the early chronic phase (CP) to the fatal blastic phase (BP). This programmed course is closely related to the translocation t(9;22)(q22;q11) and the resulting...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Domenico, Garcia-Gutierrez, José Valentín, Soverini, Simona, Baccarani, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357035/
https://www.ncbi.nlm.nih.gov/pubmed/32498406
http://dx.doi.org/10.3390/jcm9061709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357035/
https://www.ncbi.nlm.nih.gov/pubmed/32498406
http://dx.doi.org/10.3390/jcm9061709

Ejemplares similares